Dr. Reddy's Laboratories
RDY
#1699
Rank
NZ$20.54 B
Marketcap
NZ$24.56
Share price
0.35%
Change (1 day)
0.48%
Change (1 year)

Dr. Reddy's Laboratories (RDY) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : NZ$3.50 Billion

According to Dr. Reddy's Laboratories's latest financial reports the company's total liabilities are NZ$3.50 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Dr. Reddy's Laboratories - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-03-31NZ$3.21 B50.01%
2024-03-31NZ$2.14 B21.37%
2023-03-31NZ$1.76 B-9.14%
2022-03-31NZ$1.94 B7.5%
2021-03-31NZ$1.80 B4.92%
2020-03-31NZ$1.72 B-4.2%
2019-03-31NZ$1.79 B-14.52%
2018-03-31NZ$2.10 B-0.04%
2017-03-31NZ$2.10 B21.71%
2016-03-31NZ$1.72 B-3.85%
2015-03-31NZ$1.79 B17.91%
2014-03-31NZ$1.52 B-0.27%
2013-03-31NZ$1.53 B2.95%
2012-03-31NZ$1.48 B2.53%
2011-03-31NZ$1.44 B22.3%
2010-03-31NZ$1.18 B-18.64%
2009-03-31NZ$1.45 B22.6%
2008-03-31NZ$1.18 B-17.39%
2007-03-31NZ$1.43 B-16.28%
2006-03-31NZ$1.71 B537.67%
2005-03-31NZ$0.26 B39.49%
2004-03-31NZ$0.19 B19.74%
2003-03-31NZ$0.16 B-1.02%
2002-03-31NZ$0.16 B-54.28%
2001-03-31NZ$0.35 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Pfizer
PFE
NZ$200.16 B 5,609.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$56.43 B 1,509.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
NZ$106.08 B 2,926.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novartis
NVS
NZ$108.25 B 2,987.90%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$114.29 B 3,160.23%๐Ÿ‡ซ๐Ÿ‡ท France